Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

795
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
795
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

688
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
688
Analgesia and Pain Management01:25

Analgesia and Pain Management

1.3K
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
1.3K
Drug Abuse and Addiction: Pharmacological Phenomena01:15

Drug Abuse and Addiction: Pharmacological Phenomena

1.0K
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
1.0K
Opioid Receptors: Overview01:22

Opioid Receptors: Overview

3.6K
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
3.6K
Prescription, Nonprescription and Orphan Drugs01:02

Prescription, Nonprescription and Orphan Drugs

1.1K
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
1.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Physical Environment Features and Healthcare Interruptions: A Scoping Review Across Clinical Settings.

HERD·2026
Same author

The Dynamics of Attention Across Automated and Manual Driving Modes: A Driving Simulation Study.

Human factors·2026
Same author

Investigating Stress-Related Heart Rate Behavior and Rhythm in College Students Using Trend Analysis Methods.

Sensors (Basel, Switzerland)·2026
Same author

Investigating Occupational Stress in ICU Nurses: A Comparative Analysis of Mental and Physical Stress Using Heart Rate Variability and Wrist-Worn Accelerometer Data.

Human factors·2026
Same author

Serious Games for Preventing Musculoskeletal Disorders in Occupational Settings: Scoping Review.

JMIR serious games·2025
Same author

Quantifying Mental Stress Using Cardiovascular Responses: A Scoping Review.

Sensors (Basel, Switzerland)·2025

Related Experiment Video

Updated: Dec 19, 2025

Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
09:29

Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods

Published on: August 4, 2022

2.5K

Technologies for Opioid Use Disorder Management: Mobile App Search and Scoping Review.

Joseph Nuamah1, Ranjana Mehta1, Farzan Sasangohar1,2

  • 1Department of Industrial and Systems Engineering, Texas A&M University, College Station, TX, United States.

JMIR Mhealth and Uhealth
|June 6, 2020
PubMed
Summary

Technological solutions for opioid use disorder (OUD) are limited, with few mobile health (mHealth) apps available. Further research is needed to explore mHealth and wearable sensors for OUD management and withdrawal.

Keywords:
appsmHealthmobile phonesubstance abuse disorderwearable sensors

More Related Videos

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
10:17

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry

Published on: April 23, 2019

10.1K
Author Spotlight: An Efficient Methodology to Confidently Differentiate and Characterize Fentanyl Analogs
10:13

Author Spotlight: An Efficient Methodology to Confidently Differentiate and Characterize Fentanyl Analogs

Published on: November 8, 2024

2.7K

Related Experiment Videos

Last Updated: Dec 19, 2025

Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
09:29

Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods

Published on: August 4, 2022

2.5K
High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
10:17

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry

Published on: April 23, 2019

10.1K
Author Spotlight: An Efficient Methodology to Confidently Differentiate and Characterize Fentanyl Analogs
10:13

Author Spotlight: An Efficient Methodology to Confidently Differentiate and Characterize Fentanyl Analogs

Published on: November 8, 2024

2.7K

Area of Science:

  • Digital health
  • Medical informatics
  • Substance use disorder research

Background:

  • Technological advancements are driving the development of new solutions for opioid use disorder (OUD).
  • However, the application of mobile health (mHealth) technologies for OUD management lags behind that of other chronic diseases.
  • There is a need to explore innovative technological approaches for OUD.

Purpose of the Study:

  • To design OUD management technologies using wearable sensors for continuous monitoring.
  • To document available opioid-related mHealth applications.
  • To review existing technological solutions for OUD and identify opportunities for withdrawal management.

Main Methods:

  • A two-phase parallel search approach was employed.
  • Phase 1 involved an app search to identify opioid-related mHealth apps.
  • Phase 2 utilized a scoping review of literature to find relevant technologies and mHealth apps for OUD.

Main Results:

  • The app search indicated a growing number of mHealth apps, primarily clinician-facing and focused on opioid dose conversion.
  • Despite app availability, the scoping review found no studies assessing the efficacy of mHealth apps for OUD.
  • A significant gap exists in technological solutions for OUD management.

Conclusions:

  • There is a notable deficiency in current technological solutions for managing opioid use disorder.
  • Mobile health (mHealth) apps and wearable sensors present a promising avenue for addressing OUD.
  • Further investigation into the efficacy of these technologies is warranted.